1. Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol 2011;106:1582–1591; quiz 1581, 1592.
2. Jun DW, Park HY, Lee OY, et al. A population-based study on bowel habits in a Korean community: prevalence of functional constipation and self-reported constipation. Dig Dis Sci 2006;51:1471–1477.
3. Johanson JF, Kralstein J. Chronic constipation: a survey of the patient perspective. Aliment Pharmacol Ther 2007;25:599–608.
4. Choi MG. Review: Evidence based guideline for diagnosis and treatment: diagnostic guideline for constipation. Kor J Neurogastroenterol Motil 2005;11:44–50.
5. Park YS, Lee DH. Review: Evidence based guideline for diagnosis and treatment: therapeutic guideline for constipation. Kor J Neurogastroenterol Motil 2005;11:51–57.
6. Park MI, Shin JE, Myung SJ, et al. Guidelines for the treatment of constipation. Korean J Gastroenterol 2011;57:100–114.
8. Shin JE, Jung HK, Lee TH, et al. Guidelines for the diagnosis and treatment of chronic functional constipation in Korea, 2015 revised edition. J Neurogastroenterol Motil 2016;22:384–411.
9. Guidelines International Network. The ADAPTE Collaboration. ADAPTE framework [Internet]. Perthshire (SCT): Guidelines International Network, c2010. Available from:
http://www.g-i-n.net
10. Steering Committee for Clinical Practice Guideline. Adaptation process for developing Korean clinical practice guideline. Seoul: Minister of Health & Welfare, Korean Academy of Medical Science, 2011.
11. Paré P, Bridges R, Champion MC, et al. Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment. Can J Gastroenterol 2007;21 Suppl B:3B–22B.
12. American Gastroenterological Association medical position statement on constipation. Gastroenterology 2013;144:211–217.
16. Guyatt GH, Cook DJ, Jaeschke R, Pauker SG, Schünemann HJ. Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(6 Suppl):123S–131S.
19. Glia A, Lindberg G, Nilsson LH, Mihocsa L, Akerlund JE. Clinical value of symptom assessment in patients with constipation. Dis Colon Rectum 1999;42:1401–1408; discussion 1408-1410.
20. Bharucha AE, Wald A, Enck P, Rao S. Functional anorectal disorders. Gastroenterology 2006;130:1510–1518.
21. Rao SS, Welcher KD, Leistikow JS. Obstructive defecation: a failure of rectoanal coordination. Am J Gastroenterol 1998;93:1042–1050.
22. Rao SS. Dyssynergic defecation. Gastroenterol Clin North Am 2001;30:97–114.
24. Hemingway DM, Finlay IG. Effect of colectomy on gastric emptying in idiopathic slow-transit constipation. Br J Surg 2000;87:1193–1196.
25. Prather CM. Subtypes of constipation: sorting out the confusion. Rev Gastroenterol Disord 2004;4 Suppl 2:S11–S16.
26. Ravi K, Bharucha AE, Camilleri M, Rhoten D, Bakken T, Zinsmeister AR. Phenotypic variation of colonic motor functions in chronic constipation. Gastroenterology 2010;138:89–97.
27. Talley NJ, Jones M, Nuyts G, Dubois D. Risk factors for chronic constipation based on a general practice sample. Am J Gastroenterol 2003;98:1107–1111.
28. Lindberg G, Hamid SS, Malfertheiner P, et al. World Gastroenterology Organisation global guideline: constipation--a global perspective. J Clin Gastroenterol 2011;45:483–487.
29. Gallegos-Orozco JF, Foxx-Orenstein AE, Sterler SM, Stoa JM. Chronic constipation in the elderly. Am J Gastroenterol 2012;107:18–25; quiz 26.
30. Higgins PD, Johanson JF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol 2004;99:750–759.
32. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 1997;32:920–924.
33. Saad RJ, Rao SS, Koch KL, et al. Do stool form and frequency correlate with whole-gut and colonic transit? Results from a multicenter study in constipated individuals and healthy controls. Am J Gastroenterol 2010;105:403–411.
34. Rao SS, Ozturk R, Laine L. Clinical utility of diagnostic tests for constipation in adults: a systematic review. Am J Gastroenterol 2005;100:1605–1615.
35. Müller-Lissner SA, Kamm MA, Scarpignato C, Wald A. Myths and misconceptions about chronic constipation. Am J Gastroenterol 2005;100:232–242.
36. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997;112:594–642.
37. Schusselé Filliettaz S, Gonvers JJ, Peytremann-Bridevaux I, et al. Appropriateness of colonoscopy in Europe (EPAGE II). Functional bowel disorders: pain, constipation and bloating. Endoscopy 2009;41:234–239.
38. Talley NJ. How to do and interpret a rectal examination in gastroenterology. Am J Gastroenterol 2008;103:820–822.
39. Tantiphlachiva K, Rao P, Attaluri A, Rao SS. Digital rectal examination is a useful tool for identifying patients with dyssynergia. Clin Gastroenterol Hepatol 2010;8:955–960.
40. Soh JS, Lee HJ, Jung KW, et al. The diagnostic value of a digital rectal examination compared with high-resolution anorectal manometry in patients with chronic constipation and fecal incontinence. Am J Gastroenterol 2015;110:1197–1204.
41. Rao SS. Constipation: evaluation and treatment of colonic and anorectal motility disorders. Gastroenterol Clin North Am 2007;36:687–711; x.
42. Minguez M, Herreros B, Sanchiz V, et al. Predictive value of the balloon expulsion test for excluding the diagnosis of pelvic floor dyssynergia in constipation. Gastroenterology 2004;126:57–62.
43. Rao SS, Mudipalli RS, Stessman M, Zimmerman B. Investigation of the utility of colorectal function tests and Rome II criteria in dyssynergic defecation (Anismus). Neurogastroenterol Motil 2004;16:589–596.
44. Bharucha AE. Update of tests of colon and rectal structure and function. J Clin Gastroenterol 2006;40:96–103.
45. Kim JE, Rhee PL, Kim YH, et al. Clinical usefulness of KolomarkTM, a Korean radio-opaque marker for measuring colon transit time. Korean J Med 2001;60:337–341.
46. Metcalf AM, Phillips SF, Zinsmeister AR, MacCarty RL, Beart RW, Wolff BG. Simplified assessment of segmental colonic transit. Gastroenterology 1987;92:40–47.
48. Brown WJ, Mishra G, Lee C, Bauman A. Leisure time physical activity in Australian women: relationship with well being and symptoms. Res Q Exerc Sport 2000;71:206–216.
50. Johannesson E, Simrén M, Strid H, Bajor A, Sadik R. Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol 2011;106:915–922.
51. Eswaran S, Muir J, Chey WD. Fiber and functional gastrointestinal disorders. Am J Gastroenterol 2013;108:718–727.
53. Attaluri A, Donahoe R, Valestin J, Brown K, Rao SS. Randomised clinical trial: dried plums (prunes) vs. psyllium for constipation. Aliment Pharmacol Ther 2011;33:822–828.
55. Huh JW, Park YA, Sohn SK, et al. Effect of yogurt enriched water-soluble fiber on functional constipation. J Korean Soc Coloproctol 2007;23:312–320.
56. Kim JY, Kim OY, Yoo HJ, et al. Effects of fiber supplements on functional constipation. Korean J Nutr 2006;39:35–43.
57. Voderholzer WA, Schatke W, Mühldorfer BE, Klauser AG, Birkner B, Müller-Lissner SA. Clinical response to dietary fiber treatment of chronic constipation. Am J Gastroenterol 1997;92:95–98.
58. Suares NC, Ford AC. Systematic review: the effects of fibre in the management of chronic idiopathic constipation. Aliment Pharmacol Ther 2011;33:895–901.
59. Young RJ, Beerman LE, Vanderhoof JA. Increasing oral fluids in chronic constipation in children. Gastroenterol Nurs 1998;21:156–161.
60. Kinnunen O, Salokannel J. Constipation in elderly long-stay patients: its treatment by magnesium hydroxide and bulk-laxative. Ann Clin Res 1987;19:321–323.
62. Krendel DA. Hypermagnesemia and neuromuscular transmission. Semin Neurol 1990;10:42–45.
63. Tatsumi H, Masuda Y, Imaizumi H, et al. A case of cardiopulmonary arrest caused by laxatives-induced hypermagnesemia in a patient with anorexia nervosa and chronic renal failure. J Anesth 2011;25:935–938.
64. Panesar PS, Kumari S. Lactulose: production, purification and potential applications. Biotechnol Adv 2011;29:940–948.
65. Sanders JF. Lactulose syrup assessed in a double-blind study of elderly constipated patients. J Am Geriatr Soc 1978;26:236–239.
67. Lee JS, Kim YD, Im HH, et al. The effect of lactulose on the colon transit and the various symptoms of constipation in patients with functional constipation. Korean J Neurogastroenterol Motil 2006;12:127–135.
68. Carulli N, Salvioli GF, Manenti F. Absorption of lactulose in man. Digestion 1972;6:139–145.
72. Belsey JD, Geraint M, Dixon TA. Systematic review and meta analysis: polyethylene glycol in adults with non-organic constipation. Int J Clin Pract 2010;64:944–955.
73. Lee-Robichaud H, Thomas K, Morgan J, Nelson RL. Lactulose versus polyethylene glycol for chronic constipation. Cochrane Database Syst Rev 2010;7:CD007570.
76. Di Palma JA, Cleveland MV, McGowan J, Herrera JL. An open-label study of chronic polyethylene glycol laxative use in chronic constipation. Aliment Pharmacol Ther 2007;25:703–708.
77. Müller-Lissner S. Pharmacokinetic and pharmacodynamics considerations for the current chronic constipation treatments. Expert Opin Drug Metab Toxicol 2013;9:391–401.
78. Ford AC, Suares NC. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Gut 2011;60:209–218.
79. Wald A. Is chronic use of stimulant laxatives harmful to the colon? J Clin Gastroenterol 2003;36:386–389.
80. Schiller LR. Constipation and fecal incontinence in the elderly. Gastroenterol Clin North Am 2001;30:497–515.
81. Joo JS, Ehrenpreis ED, Gonzalez L, et al. Alterations in colonic anatomy induced by chronic stimulant laxatives: the cathartic colon revisited. J Clin Gastroenterol 1998;26:283–286.
82. Chmielewska A, Szajewska H. Systematic review of randomized controlled trials: probiotics for functional constipation. World J Gastroenterol 2010;16:69–75.
84. Camilleri M, Kerstens R, Rykx A, Vandeplassche L. A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med 2008;358:2344–2354.
85. Quigley EM, Vandeplassche L, Kerstens R, Ausma J. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther 2009;29:315–328.
86. Tack J, van Outryve M, Beyens G, Kerstens R, Vandeplassche L. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives. Gut 2009;58:357–365.
89. Müller-Lissner S, Rykx A, Kerstens R, Vandeplassche L. A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation. Neurogastroenterol Motil 2010;22:991–998; e255.
90. Camilleri M, Van Outryve MJ, Beyens G, Kerstens R, Robinson P, Vandeplassche L. Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies. Aliment Pharmacol Ther 2010;32:1113–1123.
92. Johanson JF, Morton D, Geenen J, Ueno R. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation. Am J Gastroenterol 2008;103:170–177.
93. Barish CF, Drossman D, Johanson JF, Ueno R. Efficacy and safety of lubiprostone in patients with chronic constipation. Dig Dis Sci 2010;55:1090–1097.
94. Lembo AJ, Schneier HA, Shiff SJ, et al. Two randomized trials of linaclotide for chronic constipation. N Engl J Med 2011;365:527–536.
98. Lee HJ, Boo SJ, Jung KW, et al. Long-term efficacy of biofeedback therapy in patients with dyssynergic defecation: results of a median 44 months follow-up. Neurogastroenterol Motil 2015;27:787–795.
99. Rao SS, Seaton K, Miller M, et al. Randomized controlled trial of biofeedback, sham feedback, and standard therapy for dyssynergic defecation. Clin Gastroenterol Hepatol 2007;5:331–338.
100. Jorge JM, Habr-Gama A, Wexner SD. Biofeedback therapy in the colon and rectal practice. Appl Psychophysiol Biofeedback 2003;28:47–61.
101. Shim LS, Jones M, Prott GM, Morris LI, Kellow JE, Malcolm A. Predictors of outcome of anorectal biofeedback therapy in patients with constipation. Aliment Pharmacol Ther 2011;33:1245–1251.
103. Gadel Hak N, El-Hemaly M, Hamdy E, et al. Pelvic floor dyssynergia: efficacy of biofeedback training. Arab J Gastroenterol 2011;12:15–19.
104. Arebi N, Kalli T, Howson W, Clark S, Norton C. Systematic review of abdominal surgery for chronic idiopathic constipation. Colorectal Dis 2011;13:1335–1343.
105. Conzo G, Allaria A, Stanzione F, et al. Laparoscopic treatment of chronic slow transit constipation. Report of three cases and review of literature. Ann Ital Chir 2012;83:113–117.
106. Redmond JM, Smith GW, Barofsky I, Ratych RE, Goldsborough DC, Schuster MM. Physiological tests to predict long-term outcome of total abdominal colectomy for intractable constipation. Am J Gastroenterol 1995;90:748–753.
107. FitzHarris GP, Garcia-Aguilar J, Parker SC, et al. Quality of life after subtotal colectomy for slow-transit constipation: both quality and quantity count. Dis Colon Rectum 2003;46:433–440.
108. Mellgren A, Anzén B, Nilsson BY, et al. Results of rectocele repair. A prospective study. Dis Colon Rectum 1995;38:7–13.
109. Bouras EP, Tangalos EG. Chronic constipation in the elderly. Gastroenterol Clin North Am 2009;38:463–480.
110. Mendoza J, Legido J, Rubio S, Gisbert JP. Systematic review: the adverse effects of sodium phosphate enema. Aliment Pharmacol Ther 2007;26:9–20.
111. Paran H, Butnaru G, Neufeld D, Magen A, Freund U. Enema-induced perforation of the rectum in chronically constipated patients. Dis Colon Rectum 1999;42:1609–1612.
112. Pinto RA, Sands DR. Surgery and sacral nerve stimulation for constipation and fecal incontinence. Gastrointest Endosc Clin N Am 2009;19:83–116; vi-vii.
113. Carrington EV, Evers J, Grossi U, et al. A systematic review of sacral nerve stimulation mechanisms in the treatment of fecal incontinence and constipation. Neurogastroenterol Motil 2014;26:1222–1237.
114. Lee KJ, Kim JH, Cho SW. Short-term effects of magnetic sacral dermatome stimulation for idiopathic slow transit constipation: sham-controlled, cross-over pilot study. J Gastroenterol Hepatol 2006;21(1 Pt 1):47–53.